Key facts
- Notable investors include Heda Ventures, Zeyue Venture Capital.
- Status: Privately Held (backing).
Investors
2- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Mainchip (Hangzhou) Life Science Technology
- ·The full record, as it builds
Funding rounds
No funding rounds for Mainchip (Hangzhou) Life Science Technology are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Mainchip (Hangzhou) Life Science Technology
Manufacturer of biomedical diagnostic devices intended for molecular testing and healthcare research purposes. The company offers portable nucleic acid detection instruments, digital PCR systems, point-of-care diagnostic devices, biochips, and supporting reagents, enabling hospitals, research laboratories, agricultural testing facilities, and food safety organizations to perform rapid and precise molecular analysis, improve disease surveillance, support cancer screening, enhance veterinary diagnostics, and strengthen environmental monitoring through scalable and reliable diagnostic capabilities.
- Sector
- Healthcare
- HQ
- Shanghai, China
- Founded
- 2018
- Employees
- 2
- Ownership
- Privately Held (backing)
Mainchip (Hangzhou) Life Science Technology doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Mainchip (Hangzhou) Life Science Technology shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Mainchip (Hangzhou) Life Science Technology in its N-PORT filings yet. We sweep new filings monthly.